Plancorp LLC’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$481K Sell
2,058
-159
-7% -$33K 0.01% 262
2026
Q1
$478K Buy
2,217
+101
+5% +$21.8K 0.01% 234
2025
Q4
$435K Sell
2,116
-13
-0.6% -$2.45K 0.01% 234
2025
Q3
$334K Sell
2,129
-13
-0.6% -$2.01K 0.01% 275
2025
Q2
$360K Buy
2,142
+28
+1% +$4.16K 0.01% 268
2025
Q1
$291K Sell
2,114
-550
-21% -$70.1K 0.01% 289
2024
Q4
$315K Sell
2,664
-17
-0.6% -$1.99K 0.01% 245
2024
Q3
$296K Buy
2,681
+5
+0.2% +$523 0.01% 253
2024
Q2
$263K Buy
2,676
+23
+0.9% +$2.34K 0.01% 253
2024
Q1
$297K Buy
2,653
+38
+1% +$4.1K 0.01% 232
2023
Q4
$264K Buy
2,615
+19
+0.7% +$1.89K 0.01% 230
2023
Q3
$225K Buy
2,596
+40
+2% +$3.62K 0.01% 238
2023
Q2
$242K Buy
+2,556
New +$216K 0.01% 218
2018
Q4
Sell
-4,115
Closed -$222K 159
2018
Q3
$222K Hold
4,115
0.09% 161
2018
Q2
$201K Sell
4,115
-1,000
-20% -$56.7K 0.08% 160
2018
Q1
$321K Hold
5,115
0.1% 116
2017
Q4
$313K Buy
+5,115
New +$316K 0.1% 126

Other funds holding CAH

Plancorp LLC's CAH Position: Q2 2026 in Review

Plancorp LLC reduced its Cardinal Health (CAH) stake by 7.2% in Q2 2026, selling an estimated $33K and leaving 2,058 shares worth $481K. The position accounts for 0.01% of the portfolio, ranked #262.

Plancorp LLC first reported a position in CAH in Q4 2017 and has held it in 17 quarters since. 551 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Plancorp LLC held 2,058 shares of Cardinal Health worth $481K as of Q2 2026.
  • Plancorp LLC sold 159 Cardinal Health shares in Q2 2026, an estimated $33K.
  • Cardinal Health made up 0.01% of Plancorp LLC's portfolio in Q2 2026, its #262 holding.
  • Plancorp LLC first reported a position in Cardinal Health in Q4 2017 and has held it in 17 quarters since.
  • 551 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Plancorp LLC's 13F filing for Q2 2026, filed 14 Jul 2026.